Dobutamine

Generic Name
Dobutamine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C18H23NO3
CAS Number
34368-04-2
Unique Ingredient Identifier
3S12J47372
Background

A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.

Indication

Indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.

Associated Conditions
Cardiac Decompensation, Coronary Artery Disease (CAD)
Associated Therapies
Intravenous inotropic therapy
Clinical Trials
Related News

Decision Support for Intraoperative Low Blood Pressure

Not Applicable
Completed
Conditions
Hypotension
Interventions
Procedure: Attending real-time decision support
Procedure: In-room real-time decision support
Procedure: Attending feedback emails
Procedure: In-room provider feedback emails
Device: Anesthesia Information Management System (AIMS)
Device: Perioperative Data Warehouse (PDW)
Procedure: General anesthesia
Device: Pager system
Procedure: Central neuraxial anesthesia
Procedure: Non-cardiac surgery
Drug: Propofol
Drug: Sevoflurane
Drug: Desflurane
Drug: Isoflurane
Drug: Ephedrine
Drug: Phenylephrine
Drug: Norepinephrine
Drug: Epinephrine
Drug: Dobutamine
Drug: Dopamine
Drug: Isoproterenol
Drug: Milrinone
Drug: Atropine
Drug: Glycopyrrolate
Drug: Vasopressin
Drug: Terlipressin
Drug: Sodium Chloride 0.9%
Drug: Ringer's lactate
Drug: Hydroxyethyl starch solutions
Drug: Fresh Frozen Plasma
Drug: Packed Red Blood Cells
Drug: Albumin solutions
Drug: Plasma-Lyte
Drug: Lidocaine
Drug: Bupivacaine
Drug: Levobupivacaine
Drug: Ropivacaine
Drug: Mepivacaine
Drug: Tetracaine
Drug: Prilocaine
Drug: Procaine
Drug: Chloroprocaine
Drug: Benzocaine
Drug: Articaine
First Posted Date
2016-04-04
Last Posted Date
2019-05-16
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
22435
Registration Number
NCT02726620
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Dobutamaine Versus Milrinone in Cardiorenal Syndrome

Phase 2
Withdrawn
Conditions
Cardiorenal Syndrome
Interventions
Drug: Milrinone
Drug: Dobutamine
First Posted Date
2015-12-31
Last Posted Date
2018-08-10
Lead Sponsor
Maimonides Medical Center
Registration Number
NCT02644057
Locations
🇺🇸

Maimonides Medical Center, Brooklyn, New York, United States

Non-invasive Early Goal Directed Therapy in Colorectal Surgery: a Feasibility Study

First Posted Date
2015-09-24
Last Posted Date
2015-10-29
Lead Sponsor
University Hospital Schleswig-Holstein
Target Recruit Count
80
Registration Number
NCT02559141
Locations
🇩🇪

Ole Broch, Kiel, Schleswig-Holstein, Germany

Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes

Not Applicable
Completed
Conditions
Diabetes-related Complications
Interventions
Drug: dobutamine
First Posted Date
2015-07-22
Last Posted Date
2019-01-18
Lead Sponsor
University of Avignon
Target Recruit Count
125
Registration Number
NCT02505451
Locations
🇫🇷

Hospital Henri Duffaut, Avignon, Paca, France

Levosimendan Versus Dobutamine for Renal Function in Heart Failure

Phase 3
Completed
Conditions
Cardiorenal Syndrome
Interventions
Drug: Levosimendan
Drug: Dobutamine
First Posted Date
2014-05-07
Last Posted Date
2020-02-25
Lead Sponsor
Göteborg University
Target Recruit Count
33
Registration Number
NCT02133105
Locations
🇸🇪

Sahlgrenska University Hospital, Gothenburg, Sweden

NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy

Completed
Conditions
Circulatory Failure
Interventions
Drug: Dobutamine
First Posted Date
2014-01-31
Last Posted Date
2016-09-05
Lead Sponsor
Brighton and Sussex University Hospitals NHS Trust
Target Recruit Count
18
Registration Number
NCT02051894
Locations
🇬🇧

Trevor Mann Baby Unit, Brighton, Sussex, United Kingdom

Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery

First Posted Date
2013-12-17
Last Posted Date
2013-12-17
Lead Sponsor
Azienda Policlinico Umberto I
Target Recruit Count
40
Registration Number
NCT02012946
Locations
🇮🇹

Francesco Pugliese, Rome, Italy

The Effects of Levosimendan During Mitral Valve Surgery

First Posted Date
2013-10-25
Last Posted Date
2013-10-25
Lead Sponsor
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Target Recruit Count
140
Registration Number
NCT01969071
Locations
🇹🇷

Kartal Kosuyolu High Speciality Training and Research Hospital, Istanbul, Turkey

Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients

First Posted Date
2013-08-29
Last Posted Date
2013-08-30
Lead Sponsor
Sheba Medical Center
Target Recruit Count
60
Registration Number
NCT01930734
Locations
🇮🇱

Leviev Heart Center, Chaim Sheba Medical Center, Ramat-Gan, Israel

Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns

Phase 2
Completed
Conditions
Hemodynamic Instability
Interventions
Drug: Placebo
Drug: Dobutamine
First Posted Date
2012-05-24
Last Posted Date
2015-03-09
Lead Sponsor
Adelina Pellicer
Target Recruit Count
127
Registration Number
NCT01605279
Locations
🇪🇸

La Paz University Hospital, Madrid, Spain

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy